Controversies in the treatments of prostate cancer  

作　　者：SUN Liang LU Jia-ju 

机构地区：[1]Shandong Univ, Dept Urol, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China

出　　处：《Chinese Medical Journal》2013年第15期2972-2977,共6页中华医学杂志（英文版）

基　　金：the grants from the Natural Science Foundation of Shandong Province，the Science and Technology Research Foundation of Jinan City

摘　　要：Prostate cancer is one of the leading causes of death in male in western countries; in addition, recently, the incidence of prostate cancer has increased rapidly in China. There are considerable variations between practices when choosing the appropriate therapy in advanced prostate cancer, but still far from satisfaction.Prostate cancer is one of the leading causes of death in male in western countries; in addition, recently, the incidence of prostate cancer has increased rapidly in China. There are considerable variations between practices when choosing the appropriate therapy in advanced prostate cancer, but still far from satisfaction.

关 键 词：androgen-deprivation therapy prostate cancer maximal androgen blockade intermittent ADT castration- resistant prostate cancer surgical treatment 

分 类 号：Q78[生物学—分子生物学]